Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”

Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a prescription, a wearable sensor and an app. Today, a new FDA designation gets the company one step closer to that goal.  Founded in 2015, Biofourmis is a digital therapeutics company that develops software to “augment” […]
https://tcrn.ch/3zRbqeW